Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer. (2022). Biomolecules and Biomedicine, 22(4), 553-559. https://doi.org/10.17305/bjbms.2021.6450